Drug recall D-0552-2023
Product
Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDC 51655-120-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Reason for recall
CGMP Deviations
Lots and codes
a) Lot #: F105692201, Exp. Date 09/30/2024; F105692203, Exp. Date 02/28/2025 b) Lot #: F105692202, Exp. Date 02/28/2025
Recall details
- Recalling firm
- Northwind Pharmaceuticals LLC, Indianapolis, IN
- Quantity
- a) 198 bottles; b) 22 bottles
- Distribution
- Nationwide with the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 16, 2023
Related products
- Glimepiride – drug information
- NDC 51655-120 Glimepiride · Glimepiride 4 mg/1 · Northwind Health Company, LLC